Molecular biological features of cyst wall of adamantinomatous craniopharyngioma

被引:6
|
作者
Zhao, Chuan [1 ,6 ]
Wang, Ye [2 ]
Liu, Hongxing [1 ,3 ]
Qi, Xueling [4 ]
Zhou, Zhongqing [1 ]
Wang, Xianlong [5 ]
Lin, Zhixiong [1 ]
机构
[1] Capital Med Univ, Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Second Affiliated Hosp, Xiamen Med Coll, Dept Neurosurg, Xiamen, Fujian, Peoples R China
[3] Capital Med Univ, Ditan Hosp, Dept Neurosurg, Beijing, Peoples R China
[4] Capital Med Univ, Sanbo Brain Hosp, Dept Pathol, Beijing, Peoples R China
[5] Fujian Med Univ, Sch Med Technol & Engn, Dept Bioinformat, Key Lab Minist Educ Gastrointestinal Canc, Fuzhou, Fujian, Peoples R China
[6] Capital Med Univ, Sanbo Brain Hosp, Dept Neurooncol, Beijing, Peoples R China
关键词
BETA-CATENIN; PEDIATRIC CRANIOPHARYNGIOMA; MALIGNANT-TRANSFORMATION; SURGICAL-TREATMENT; WNT PATHWAY; IDENTIFICATION; PATHOGENESIS; EXPERIENCE; CHILDREN;
D O I
10.1038/s41598-023-29664-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The molecular biological differences between cyst walls and those in solid bodies are the foundation of the outcomes. In this study, the CTNNB1 mutations were confirmed by DNAsequencing; CTNNB1 expression levels were detected by PCR; the differences between solid bodies and cyst walls in proliferative capacity and tumor stem cell niches were assessed by immunohistochemistry; the effect of the residual cyst wall on recurrence was assessed by follow-up. Mutations in the CTNNB1 in the cyst wall and the solid body were identical in each case. No differences were found in the transcriptional level of CTNNB1 between the cyst walls and the solid bodies (P = 0.7619). The cyst wall showed a pathological structure similar to the solid body. Proliferative capacity of cyst walls was stronger than that of solid body (P = 0.0021), and beta-catenin nuclear positive cells (cell clusters) in cyst walls were more than that in solid tumor (P = 0.0002). The retrospective 45 ACPs showed residual cyst wall was significantly associated with tumor recurrence or regrowth (P = 0.0176). Kaplan-Meier analysis showed there was a significant difference in the prognosis between GTR and STR (P < 0.0001).The cyst wall of ACP contained more tumor stem cell niches which could lead to the recurrence. According to the above-mentioned, a special attention to the management of the cyst wall should be paid.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Molecular biological features of cyst wall of adamantinomatous craniopharyngioma
    Chuan Zhao
    Ye Wang
    Hongxing Liu
    Xueling Qi
    Zhongqing Zhou
    Xianlong Wang
    Zhixiong Lin
    Scientific Reports, 13
  • [2] CYST WALL OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA CONTAINS TUMOR CELLS THAT COULD LEAD TO RECURRENCE AFTER SURGERY
    Zhao, Chuan
    Wang, Ye
    Liu, Hongxing
    Qi, Xueling
    Zhou, Zhongqing
    Lau, Ching
    Lin, Zhixiong
    NEURO-ONCOLOGY, 2020, 22 : 456 - 456
  • [3] Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
    Martinez-Barbera, J. P.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2015, 41 (06) : 721 - 732
  • [4] MOLECULAR ANALYSES DEMONSTRATE AN IMMUNOSUPPRESSIVE PHENOTYPE IN THE CYST AND SOLID TUMOR COMPARTMENTS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA
    Donson, Andrew
    Griesinger, Andrea
    Amani, Vladimir
    Witt, Davis
    Apps, John
    Grant, Gerald
    Dudley, Roy
    Jackson, Eric
    Johnston, James
    Greenfield, Jeffrey
    Naftel, Robert
    Limbrick, David
    Anderson, Richard C. E.
    Niazi, Toba
    Handler, Michael
    Mulcahy-Levy, Jean
    Martinez-Barbera, Juan Pedro
    Foreman, Nicholas
    Hankinson, Todd C.
    NEURO-ONCOLOGY, 2017, 19 : 28 - 28
  • [5] Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma
    Donson, Andrew M.
    Apps, John
    Griesinger, Andrea M.
    Amani, Vladimir
    Witt, Davis A.
    Anderson, Richard C. E.
    Niazi, Toba N.
    Grant, Gerald
    Souweidane, Mark
    Johnston, James M.
    Jackson, Eric M.
    Kleinschmidt-DeMasters, Bette K.
    Handler, Michael H.
    Tan, Aik-Choon
    Gore, Lia
    Virasami, Alex
    Gonzalez-Meljem, Jose Mario
    Jacques, Thomas S.
    Martinez-Barbera, Juan Pedro
    Foreman, Nicholas K.
    Hankinson, Todd C.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (09): : 779 - 788
  • [6] Unicystic Ameloblastomatoid Cystic Craniopharyngioma: Pathological Discussion and Clinical Significance of Cyst Formation in Adamantinomatous Craniopharyngioma
    Okada, Tomu
    Fujitsu, Kazuhiko
    Ichikawa, Teruo
    Miyahara, Kousuke
    Tanino, Shin
    Niino, Hitoshi
    Yagishita, Saburou
    PEDIATRIC NEUROSURGERY, 2016, 51 (03) : 158 - 163
  • [7] Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
    Martinez-Barbera, Juan Pedro
    Buslei, Rolf
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2015, 28 (1-2): : 7 - 17
  • [8] Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice
    Apps, John Richard
    Martinez-Barbera, Juan Pedro
    NEUROSURGICAL FOCUS, 2016, 41 (06)
  • [9] Effects of Simvastatin on Inflammatory Response and Biological Behaviour of Adamantinomatous Craniopharyngioma
    Li, Weizhao
    Zhang, Yunxiao
    Zhuang, Yishan
    Chen, Rongjun
    Xiong, Zhiwei
    Li, Kai
    Liu, Fang
    Xu, Haiyan
    Li, Danling
    Peng, Junxiang
    NEUROENDOCRINOLOGY, 2024, 114 (10) : 934 - 949
  • [10] RESPONSE OF T-CELLS UNDER THE INFLUENCE OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA CYST FLUID
    Vijmasi, Trinka
    Prince, Eric
    Whelan, Ros
    Griesinger, Andrea
    Donson, Andrew
    Staulcup, Susan
    Hoffman, Lindsay
    Foreman, Nicholas
    Handler, Michael
    Hankinson, Todd
    NEURO-ONCOLOGY, 2019, 21 : 95 - 95